Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunocytochemistry [3]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-90724 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD11b Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- Immunogen sequence: PQEDSDIAFL IDGSGSIIPH DFRRMKEFVS TVMEQLKKSK TLFSLMQYSE EFRIHFTFKE FQNNPNPRSL VKPITQLLGR THTATGIRKV VRELFNITNG ARKNAFKILV VITDGEKFGD PLGYEDVIPE ADREGVIRYV IGVGDAFRSE KSRQELNTIA SKPPRDHVFQ VNNFEALKTI QNQLREKIFA IEGTQT Positive Samples: THP-1, Mouse spleen, Mouse lung; Cellular Location: Membrane, Single-pass type I membrane protein
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1.88 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Blending with transition metals improves bioresorbable zinc as better medical implants.
Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor.
Neuroprotective effect of tormentic acid against memory impairment and neuro‑inflammation in an Alzheimer's disease mouse model.
Su Y, Fu J, Zhou J, Georgas E, Du S, Qin YX, Wang Y, Zheng Y, Zhu D
Bioactive materials 2023 Feb;20:243-258
Bioactive materials 2023 Feb;20:243-258
Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor.
Li Y, Qiao K, Zhang X, Liu H, Zhang H, Li Z, Liu Y, Sun T
iScience 2021 Dec 17;24(12):103392
iScience 2021 Dec 17;24(12):103392
Neuroprotective effect of tormentic acid against memory impairment and neuro‑inflammation in an Alzheimer's disease mouse model.
Cui W, Sun C, Ma Y, Wang S, Wang X, Zhang Y
Molecular medicine reports 2020 Aug;22(2):739-750
Molecular medicine reports 2020 Aug;22(2):739-750
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemistry-Immunofluorescence analysis of CD11b was performed in THP-1 cells using CD11b Polyclonal Antibody (Product # PA5-90724).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemistry-Immunofluorescence analysis of CD11b was performed in RAW264.7 cells using CD11b Polyclonal Antibody (Product # PA5-90724) at a dilution of 1:100. Blue: DAPI for nuclear staining.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemistry-Immunofluorescence analysis of CD11b was performed in THP-1 cells using CD11b Polyclonal Antibody (Product # PA5-90724).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 3. TA treatment decreases the area of CD11b-positive cells in amyloid beta precursor protein/presenilin 1 transgenic mice. Cells were visualized by immunohistochemical staining and the area of CD11b-positive cells was compared with the vehicle treatment group. (A) CD11b-positive cells in the PFC, indicated by white arrow. (B) CD11b-positive cells in the HC. Scale bar, 40 um. (C) Area of CD11b-positive cells in the PFC. (D) Area of CD11b-positive cells in the HC. Data are expressed as the mean +- SEM for the immunopositive area as % of the total surface area. n=5 in each group. **P
